# Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

> **NCT06827262** · — · RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 1500 (estimated)

## Conditions studied

- Chronic Low-back Pain
- Vertebrogenic Pain Syndrome

## Interventions

- **DEVICE:** Intracept™ Intraosseous Nerve Ablation

## Key facts

- **NCT ID:** NCT06827262
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-26
- **Primary completion:** 2034-07
- **Final completion:** 2034-07
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06827262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06827262, "Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT06827262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*